XXIX CONGRESSO NAZIONALE ASSOCIAZIONE ITALIANA PER LO STUDIO DEL PANCREAS

Transcript

1 ALMA MATER STUDIORUM UNIVERSITA DI BOLOGNA XXIX CONGRESSO NAZIONALE ASSOCIAZIONE ITALIANA PER LO STUDIO DEL PANCREAS Presidente: Lucio Gullo Bologna, Aula Magna Policlinico S. Orsola Settembre 2005 PROGRAMMA

2 2 Con il Patrocinio di: Università degli Studi, Bologna Facoltà di Medicina e Chirurgia, Bologna Azienda Ospedaliero-Universitaria, Bologna In copertina: Cellula Pancreatica. Da: Inside the body. Per gentile concessione di OGM- One Global Medicine s.r.l. Milano.

3 3 ASSOCIAZIONE ITALIANA STUDIO PANCREAS Presidente: V. Di Carlo Segretario: A. Zerbi Consiglieri: D. Basso, V. Corleto, L. Frulloni, M. Del Chiaro, R. Pezzilli, D. Russello PRESIDENTE DEL CONGRESSO L. Gullo Istituto Medicina Interna Ospedale S.Orsola, Bologna TEL.: FAX: SEGRETERIA SCIENTIFICA R. Pezzilli Dipartimento di Medicina Interna e Gastroenterologia Ospedale S.Orsola, Bologna TEL: FAX : pezzilli@aosp.bo.it COMITATO SCIENTIFICO L. Calculli, R. Casadei, G. Gavelli, M. Migliori, F. Minni, P. Tomassetti, M. Ventrucci COMITATO ORGANIZZATIVO M. Manca, M.A. Brunetti, G. Ubaldi, D. Campana, L. Piscitelli ATTESTATO DI PARTECIPAZIONE A tutti i partecipanti in regola con l iscrizione all AISP o con la quota di iscrizione al Congresso sarà rilasciato l attestato di partecipazione ECM Il congresso è stato accreditato di 10 punti SEGRETERIA ORGANIZZATIVA OSC HEALTHCARE Via Santo Stefano, Bologna Tel: Fax: info@oscbologna.com URL:

4 4 GIOVEDI 15 Settembre Comunicazioni Moderatori: L.Frulloni, P.Billi Casi Clinici 1. A mediastinic mass of unknown origin - Rocchetti S. 2. Intraductal endocrine tumour of the pancreas: report of two cases. - Reghellin D. 3. Early pancreatic cancer and Peuts-Jeghers syndrome: a case report. - Zanini N. 4. Old done idiopathic chronic pancreatitis diagnosis: a slippery issue. case report. - Landoni L. 5. Neuroendocrine tumor of the pancreas and GIST: is there a correlation? - Pagogna S. 6. Intraductal oncocytic papillary adenocarcinoma of the pancreas. - Franceschetti L. 7. A case of pancreatic heterotopy of duodenal wall, intraductal papillary mucinous tumour and intraepithelilal neoplasm of pancreas, papillary carcinoma of kidney in a single patient. - Nobili C. 8. A misleading intrapancreatic accessory spleen mimicking a nonfunctional neuroendocrine tumor of the pancreas. - Panier Suffat L. 9. EUS-guided puncture of pancreatic duct (PD) with methylene blue (MB) injection for localization of the pancreatic orifice after ampullectomy. - Rossi M.

5 Presentazione Progetti Nazionali AISP Moderatori: D. Russello, D. Basso Pancro Inf - A. Gabrielli Pancro Gen - G.M. Cavestro Pro Inf - G. Uomo Genetica del cancro del pancreas - S. Presciuttini Tumori endocrini - A. Zerbi Lettura Moderatore: E. Roda Quale ruolo oggi per le Pancreas Unit? Relatore: V. Di Carlo Apertura del Congresso e saluto delle Autorità Lucio Gullo Presidente del Congresso Pier Ugo Calzolari Rettore dell Università di Bologna Maria Paola Landini Preside della Facoltà di Medicina e Chirurgia della Università di Bologna Paolo Cacciari Direttore Generale Azienda Ospedaliero- Universitaria di Bologna Valerio Di Carlo Presidente dell Associazione Italiana Studio Pancreas

6 6 VENERDI 16 Settembre Comunicazioni Moderatori: R. Corinaldesi, P. A. Testoni 1. The quality of life in patients with chronic pancreatitis evaluated using the SF-12 questionnaire: a comparative study with the SF-36 questionnaire. - Pezzilli R. 2. A prospective comparison of secretin enhanced MRCP and EUS in patients with non alcoholic non biliary acute recurrent pancreatitis. - Mangiavillano B. 3. A study of the relationship between idiopathic pancreatic hyperenzymemia and dyslipidemia. - Manca M. 4. IgG type 4 are not specific for autoimmune pancreatitis. - Coato E. 5. Common bile duct strictures due to chronic pancreatitis managed by self-expandable metal stents (SEMS): result of a long-term follow-up study. - Iacopini F. 6. Nosocomial non-biliopancreatic infections in acute pancreatitis. - Menchise A. 7. Hepatobiliary scintigraphy and magnetic resonance cholangio-pancreatography (MRCP) with secretin stimulation (MRCP+S) in patients suffering from recurrent pancreatitis (RP). - Tomba F. 8. The impact of timing on the efficacy of Foy in the prevention of acute pancreatitis: a randomized study comparing prior vs after-ercp administration. - Manes G. 9. CFTR, SPINK1 and PRSS1 genes mutations in patients affected by sporadic chronic pancreatitis. - Salacone P.

7 Lettura Moderatore: G. Biasco La chemioterapia e la radioterapia nel carcinoma pancreatico. Attualità e prospettive future Relatore: G. Boz Coffee break Comunicazioni Moderatori: D. Cucinotta, P.L. Costa 1. Preclinical studies for the development of active immunotherapy in pancreatic adenocarcinoma. - Filipazzi P. 2. Angiogenesis factors are likely related to the motility behavior of pancreatic cancer cell lines. - Bonora A. 3. Isolation and characterization of pancreatic cancer (PC) diabetogenic factor: 1 14 aminoacids peptide corresponding to the N-terminal sequence of an s-100 calcium binding protein. - Greco E. 4. Mitochondrial DNA (mtdna) mutations: new insigths for pancreatic cancer diagnosis and prognosis. - Fogar P. 5. Effect of the genetic inactivation of kinase activity of phosphoinositide 3-kinase (P13K) in experimental acute pancreatitis. - Goffi A. 6. Increased levels of interleukin-18 binding protein in the blood circulation of the patients with pancreatic adenocarcinoma: a potential novel mechanism of tumor immune escape? - Tonel E Tavola Rotonda Moderatori: P.Pederzoli, G.Gavelli Tecniche di immagine nella pancreatite acuta necrotica Le richieste del clinico - P. Pederzoli

8 8 TAC - L.Calculli RMN - A. Vanzulli Ecoendoscopia - G. Caletti Le risposte del radiologo - G.Gavelli Lunch - Visita ai poster (Moderatori: M. Del Chiaro, V. Corleto, P.G. Rabitti) Tavola Rotonda Moderatori: M. Noronha, M. Ventrucci La qualità di vita nella pancreatite cronica R. Pezzilli, G.L. Di Sebastiano, A. Mariani Comunicazioni Moderatori: S. Pedrazzoli, E. Gaia 1. Obesity and the risk of pancreatic cancer: an Italian multicenter study. - Fantini L. 2. Prognosis factors for resected pancreatic cancer: a proposal for a prognostic score. - Scaltrini F. 3. Surgical and/or conservative management of branch duct intraductal papillary mucinous neoplasms: a prospective study on 118 patients. Crippa 4. Pancreaticogastrostomy (PG) versus pancreaticojejunostomy (PJ) after pancreaticoduodenectomy (PD). A prospective randomized study. - Molinari E. 5. Recurrence rate according to the resection pancreatic margin histology in intraductal papillary mucinous neoplasm of the pancreas. - Serini P. 6. Preliminary results of a phase ii trial of dose-intense PEFG

9 9 (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma. - Cereda S. 16:30 Coffee Break 16:45 Comunicazioni Moderatori: E. Iovine, A. Malesci 1. Conventional ultrasonography, contrast-enhanced ultrasonography, and contrast-enhanced computed tomography in detection of liver metastases in patients with endocrine tumours of the pancreas a preliminary comparative study. - Serra C. 2. Endoscopic management of external biliary fistula after duodenopancreatectomy. - Mutignani M. 3. Peripancreatic vascular anatomic variations: impact of radiological diagnosis with multidetector computed tomography (MDCT) on surgical strategy. - Pascali E. 4. Magnetic resonance cholangio-pancreatography (MRCP) in asymptomatic hyperamylasemia. - Malagò R. 5. Non-functioning neuroendocrine tumours (NFET): role of CT in the differential diagnosis with ductal adenocarcinoma of the pancreas. Tapparelli M. 6. Multidetector CT in evaluation of the retroportal pancreatic lamina: correlations with histopathological findings - Mazzeo S Assemblea Generale Cena Sociale (Palazzo Isolani)

10 10 SABATO 17 Settembre Comunicazioni Moderatori: F. Minni, A. Gabbrielli 1. A second look to anti-tnf treatment in acute pancreatitis (AP): thumb down? - Marotta F. 2. Pancreatic cancer and immunosuppression: effects of interleukin-2 on T-lymphocytes subpopulations in the perioperative period - Degrate L. 3. Laser microdissection in pharmacological study of pancreatic cancer - Funel N. 4. Prognostic value of Ki-67 expression in the cytological identification of pancreatic endocrine tumours: preliminary data - Manzoni M. 5. Islet-1 expression in human pancreas and in pancreatic endocrine tumours - Albarello L. 6. No pathological and/or clinical parameters can predict the response to somatostatin analogues in advanced pancreatic endocrine well differentiated carcinomas - Bettini R. 7. Surgical treatment of non -functioning pancreatic islet cell tumours - Pagogna S. 8. Pancreatic neuroendocrine tumour excision - 25 years experience - Pasquali C. 9. Non-functioning endocrine pancreatic tumours: factors predicting recurrence and outcome - Capitanio V Miniletture Moderatore: C. Pasquali Il tumore pancreatico solido cistico papillare Istopatologia - D. Santini

11 11 Chirurgia - R. Casadei Coffee break Miniletture Moderatore: G.C. Delle Fave Tumori endocrini pancreatici Terapia medica - P. Tomassetti Terapia chirurgica - M. Falconi Comunicazioni Moderatori: G. Masoero, M. Bernardi 1. Characteristics of pancreatic fistula after pancreatic resections - Frasson M. 2. Therapeutic perspectives of patients with locally advanced pancreatic cancer - Beneduce A. 3. Pharmacogenetics of gemcitabine in pancreatic cancer - Giovannetti E. 4. Role of surgery in pancreatic metastases from renal cell carcinoma - Ortolano E FDG PET is very useful in the follow-up after resection of pancreatic and periampullary tumours - Sperti C. 6. Mesenteric portal vein resection during pancreatectomy for ductal adenocarcinoma of the pancreas: is it worthwile? - Boggi U Consegna Premi AISP Chiusura del Congresso